EMEA-000469-PIP01-08-M07
Key facts
| Invented name |
Ecalta
|
| Active substance |
anidulafungin
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0053/2017
|
| PIP number |
EMEA-000469-PIP01-08-M07
|
| Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of invasive candidiasis
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Pfizer Limited
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000469-PIP01-08-M07
|
| Compliance opinion date |
26/04/2019
|
| Compliance outcome |
positive
|